Skip to Main Content

Laura L. Koth


Co-director, UCSF Interstitial Lung Disease Center of Excellence

Dr. Laura Koth is a pulmonologist and an expert in interstitial lung disease. She is co-director of UCSF's interstitial lung disease center of excellence.

Koth's research activities focus on the mechanisms of lung inflammation and macrophage activation. Macrophages are a type of white blood cell with important roles in immune response.

Koth earned her medical degree from Harvard Medical School. She completed residency training in internal medicine at Massachusetts General Hospital, followed by a fellowship in pulmonary and critical care medicine UCSF. She joined the UCSF faculty in 2003.

  • Education

    Harvard University School of Medicine, 1994

  • Residencies

    Massachusetts General Hospital, Internal Medicine, 1997

  • Fellowships

    UCSF Medical Center, Pulmonary Disease, 2003

  • Board Certifications

    Pulmonary Disease, American Board of Internal Medicine

  • Academic Title



"I'm excited that the next 10 years of research on interstitial lung disease are going to be absolutely amazing."

Where I see patients (2)

    My reviews


    Overall Experience
    39 Ratings
    About our process
    Sep 26, 2023
    Dr. Laura Koth is the best.
    Jun 08, 2023
    Dr Koth is an amazing doctor. So very smart with great compassion in treatment of her patients.
    Apr 01, 2023
    Dr. Laura Koth is an exceptional physician. I am receiving excellent care from her.
    Nov 19, 2022
    I think she's great. Easy to discuss things with and extremely helpful in answering questions to put me at ease!
    Nov 19, 2022
    Very well informed and thorough.
    Sep 15, 2022
    Dr Laura Koth made me feel so comfortable and explained In detail my diagnosis and future treatments that I would require
    Aug 29, 2022
    I felt very comfortable talking and asking questions.
    Aug 29, 2022
    I honestly couldn't come up with one complaint if I were forced.
    Jul 11, 2022
    Dr. Koth has been an excellent doctor for me and explains diagnosis and other information in a simple to understand way. I am glad to have her as one of the doctors I see and receive treatment.
    May 03, 2022
    We really love Dr. Koth. Unfortunately UCSF has no pulmonologists specializing in tuberous sclerosis which can cause LAM so we'll probably have to go to Stanford to get very knowledgeable care.

    My work

    Inside the Interstitial Lung Disease (ILD) Program

    Learn how Dr. Koth and her team leverage research, collaboration and the latest medications to support patients with ILD.

    Decorative Caduceus

    Use of CXCL9 as a Biomarker of Acthar Efficacy